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AbstrACt
Introduction Cardiac rehabilitation (CR) improves health- 
related quality of life and reduces hospital admissions. 
However, patients with heart failure (HF) often fail to attend 
centre- based CR programmes. Novel ways of delivering 
healthcare, such as home- based CR programmes, may 
improve uptake of CR. Rehabilitation EnAblement in CHronic 
Heart Failure (REACH- HF) is a new, effective and cost- 
effective home- based CR programme for people with HF. 
The aim of this prospective mixed- method implementation 
evaluation study is to assess the implementation of the 
REACH- HF CR programme in the UK National Health 
Service (NHS). The speciic objectives are to (1) explore 
NHS staff perceptions of the barriers and facilitators to 
the implementation of REACH- HF, (2) assess the quality of 
delivery of the programme in real- life clinical settings, (3) 
consider the nature of any adaptation(s) made and how they 
might impact on intervention effectiveness and (4) compare 
real- world patient outcomes to those seen in a prior clinical 
trial.
Methods and analysis REACH- HF will be rolled out in 
four NHS CR centres across the UK. Three healthcare 
professionals from each site will be trained to deliver the 
12- week programme. In- depth qualitative interviews and 
focus groups will be conducted with approximately 24 NHS 
professionals involved in delivering or commissioning the 
programme. Consultations for 48 patients (12 per site) will 
be audio recorded and scored using an intervention idelity 
checklist. Outcomes routinely recorded in the National Audit 
of Cardiac Rehabilitation will be analysed and compared 
with outcomes from a recent randomised controlled trial: 
the Minnesota Living with HF Questionnaire and exercise 
capacity (Incremental Shuttle Walk Test). Qualitative research 
indings will be mapped onto the Normalisation Process 
Theory framework and presented in the form of a narrative 
synthesis. Results of the study will inform national roll- out of 
REACH- HF.
Ethics and dissemination The study (IRAS 261723) 
has received ethics approval from the South Central 
(Hampshire B) Research Ethics Committee (19/SC/0304). 
Written informed consent will be obtained from all health 
professionals and patients participating in the study. The 
research team will ensure that the study is conducted 
in accordance with the Declaration of Helsinki, the Data 
Protection Act 2018, General Data Protection Regulations and 
in accordance with the Research Governance Framework 
for Health and Social Care (2005). Findings will be published 
in scientiic peer- reviewed journals and presented at local, 
national and international meetings to publicise and explain 
the research methods and indings to key audiences to 
facilitate the further uptake of the REACH- HF intervention.
trial registration ISRCTN86234930.
IntroduCtIon
Heart failure
Approximately 900 000 people are affected 
by heart failure (HF) in the UK.1 Due to an 
strengths and limitations of this study
 Ź This will be the irst study to investigate the real- 
world implementation of a home- based cardiac re-
habilitation programme in the UK and also to include 
the evaluation of the real- world clinical effective-
ness of the programme.
 Ź The study will use Normalisation Process Theory as 
a theoretical framework to guide data collection and 
interpretation.
 Ź The qualitative indings will inform the development 
of an implementation manual for policymakers, 
planners, providers and commissioners of cardiac 
rehabilitation services for patients with heart failure.
 Ź A possible limitation of the study is that the four cen-
tres that will be appointed to implement the REACH- 
HF programme are large, well- established cardiac 
rehabilitation treatment centres and might not be 
representative of the national cardiac rehabilitation 
landscape—a potential sample bias towards early 
adopters.
 Ź This study may have limited generalisability outside 
the UK.
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ageing population, HF is becoming a national health-
care challenge.2 HF has a high impact on both patients 
and society; it can reduce exercise tolerance and healthဨ
related quality of life (HRQoL), increase the risk of 
mortality and unplanned hospital admissions and is asso-
ciated with high healthcare costs.3 There is also a consider-
able burden on the friends and family of people with HF.4 
Exercise- based cardiac rehabilitation (CR) programmes 
have been shown to enhance HRQoL in patients with HF 
and reduce unplanned hospital admissions.3 5 With suffi-
cient adherence, these benefits are consistently achieved 
in trial settings with both centre- based and home- based 
CR.3 Although the National Institute of Health and Care 
Excellence (NICE) recommends that all patients with HF 
receive CR,6 due to the frailty and poor health of this clin-
ical population, as well as dislike of group- based exercise 
and practical constraints (eg, transportation), participa-
tion in centre- based CR remains poor.7 Underutilisation 
of CR among this clinical population has been high-
lighted in the 2010 NICE guideline, with the uptake of 
CR being much lower than predicted and estimated at 
5.3%.8
rehabilitation EnAblement in CHronic Heart Failure
The Rehabilitation EnAblement in CHronic Heart Failure 
(REACH- HF) programme is a new CR programme for 
patients with HF and their caregivers, aimed at achieving 
better HRQoL in the comfort of the patient’s home. The 
12- week, facilitated, home- based intervention was code-
veloped with patients, caregivers and clinicians,9 using an 
intervention mapping approach.10 In recent randomised 
controlled trials (RCTs), REACH- HF resulted in significant 
clinical improvements in HRQoL and was cost- effective, 
with a cost falling within the current National Health 
Service (NHS) tariff for CR in the UK.11 12 REACH- HF 
therefore provides an affordable, evidence- based, patient- 
centred alternative to centre- based CR. This provides a 
way to address the latest NICE guidance recommenda-
tion that patients with HF are offered ‘a personalised, 
exercise- based CR programme in a format and setting (at 
home, in the community or in the hospital) that is easily 
accessible for the person’.6
Implementation science: negotiating the research-to-practice 
gap
Research and development within the NHS is world 
leading. However, the NHS falls short when scaling 
up well- evidenced innovations or good practice.13 The 
spread of innovations and evidence- based interventions 
across the NHS and other healthcare systems is subjected 
to various challenges.14 First, moving complex inter-
ventions from research settings to real- world clinical 
implementation is a slow process.15 Some of the barriers 
slowing down this process include the characteristics of 
the intervention itself such as its usability or fit with the 
existing processes in the organisation. Beyond this, indi-
vidual or organisational barriers include the attitudes 
towards change and the innovation itself, resources 
available, expertise, time and competing priorities.16
Second, following uptake, the same intervention 
does not always perform in exactly the same way across 
different organisations. For example, there may be 
differences in the characteristics of the people involved. 
In clinical trials, patients tend to be included based 
on predetermined criteria and such criteria are rigor-
ously checked prior to study participation. However, 
in practice, a broader patient population may end up 
using the intervention. There may also be differences 
in the characteristics of the organisations delivering 
the intervention in terms of access to resources, staff 
and expertise, compared with those available in clinical 
trials. With these differences in population character-
istics and access to resources, unplanned adaptations 
may occur to better fit the new context. This initially 
slows down the process of implementation and also 
means that the intervention is no longer delivered as 
it was under clinical trial conditions.17 Such unplanned 
adaptations often result in the interventions initially 
failing to reproduce the results that are found within 
the context of RCTs.18 With a varied and ever changing 
healthcare landscape, it is crucial to understand the full 
complexity of implementing innovations into real- world 
clinical practice.19 It is particularly important to explore 
how much of the intervention can or cannot change 
(and in what ways) without jeopardising the benefits of 
the intervention.20
Healthcare evaluations and improvement projects 
often consider performance at the level of individual 
healthcare professional,21 targeting the professional’s 
knowledge, routines and attitudes.22 However, there is 
a need for wider reaching system- level evaluations of 
the implementation process that also take into account 
community, organisational, system- level and policy- level 
influences.23
Overall, implementation science aims to examine the 
process of implementation of healthcare innovations, 
in particular, the barriers and facilitators, as observed 
in real- life clinical settings.24 To narrow the research- 
to- practice gap, implementation scientists recommend 
that the process of implementation is considered and 
built into the intervention design and development, 
the context and systems of implementation are assessed 
during the implementation efforts and key stake-
holders are involved in the intervention development 
stage through to dissemination, implementation and 
evaluation.23
Aims of the project
The current project aims to implement REACH- HF in 
four UK NHS CR services to (1) explore the facilitators 
of, and barriers to, implementation of REACH- HF in 
the existing UK CR services, (2) assess the implementa-
tion fidelity, (3) the extent and nature of any potential 
adaptations to the intervention content and how such 
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adaptations impact on effectiveness and (4) compare 
real- world outcomes to the clinical trial findings.
MEtHods And AnAlysIs
design
We will conduct a mixed- method implementation evalu-
ation study using in- depth semistructured interviews with 
key NHS staff, analysis of pre–post intervention changes 
in routinely collected outcome data via the British Heart 
Foundation founded National Audit of Cardiac Rehabili-
tation (NACR) and a fidelity assessment using a checklist 
applied to recordings of provider–patient interactions.
In- depth semistructured interviews will be used to iden-
tify facilitators of, and barriers to, implementation. Audio 
recordings of REACH- HF clinical encounters will be used 
to assess fidelity. Quantitative data obtained from the 
NACR will be used to compare real- world outcomes to the 
clinical trial findings. Data gathered from all of the above 
study activities (interviews, fidelity assessment, patient 
outcomes) will be used to assess the extent and nature 
of adaptations to the intervention content and how such 
adaptations are associated with effectiveness.
setting and site recruitment
The study will be conducted in four UK NHS CR centres 
(desirably from the four UK countries) which will be 
early adopters of the REACH- HF programme and known 
as ‘Beacon Sites’. The opportunity to apply to become a 
Beacon Site will be promoted at national (UK) confer-
ences and local meetings of CR practitioners. Interested 
CR services will be sent an information pack including an 
application form. Applicants will be asked to provide infor-
mation on their NACR National Certification Programme 
for CR status (NCP_CR), number of referrals made to the 
CR service (for both cardiac patients and patients with a 
primary diagnosis of HF), whether the service is offering 
home- based programme, length of current programmes, 
number of programme completions, number of pre 
and post- treatment assessment completions, as well as to 
comment on willingness to engage in research and host 
site visits for other interested parties.
The NCP_CR is a national certification programme for 
CR issued jointly by the British Association for Cardiovas-
cular Prevention and Rehabilitation (BACPR) and the 
NACR. The certification programme rates CR services 
on seven key performance indicators (KPIs). KPIs are the 
NACR measurable indicators based on the BACPR core 
components. Programmes need to meet at least four KPIs 
to be granted an amber status and all seven to be granted a 
green status (2019 NACR Quality and Outcomes report).
The sites will be recruited from across the UK using a 
two- stage application process (application form followed 
by panel interview for shortlisted sites). As an incen-
tive, sites will be offered free intervention materials for 
the treatment of 50 patients (ie, the REACH- HF patient 
manual, the Family and Friends Resource, audio with 
relaxation techniques and chair- based exercise digital 
versatile disc (DVD)). In addition, the selected sites will 
be offered free training (including training manuals) for 
three health professionals to deliver REACH- HF, post- 
training support and formative feedback on performance. 
The 3- day training will be delivered by the Heart Manual 
Department (HMD), NHS Lothian in Edinburgh.
To be eligible, sites have to be:
 Ź NACR electronically registered sites with high- quality 
status from the past audit period (green or amber 
status) operating in the UK.
 Ź Committed to delivering REACH- HF to 50 patients 
over the 12- month Beacon Site project period.
 Ź Able to release three healthcare professionals (or 
more) with relevant experience in CR and/or HF for 
3 days training plus one self- directed pretraining day.
 Ź Able to engage in research to evaluate performance 
(ie, recording some intervention sessions and staff 
participation in interviews).
 Ź Willing to host site visits and/or share informa-
tion and/or experiences with other interested NHS 
parties.
 Ź Conduct baseline and post- treatment assessment of 
HRQoL using the Minnesota Living with Heart Failure 
Questionnaire (MLHFQ)25 and exercise capacity 
using the Incremental Shuttle Walk Test (ISWT)26 for 
all patients receiving the REACH- HF programme.
study population
Healthcare providers: we aim to recruit up to 24 health-
care professionals. The total number will include the 12 
health professionals delivering REACH- HF and other key 
NHS staff involved in the delivery, planning and commis-
sioning of CR for patients with HF. To identify key staff 
involved in CR services, the study will use a combina-
tion of opportunity sampling (all available staff trained 
to deliver the REACH- HF programme) and snowball 
sampling (staff who are identified by the existing partici-
pants as having a key role in delivering or commissioning 
of CR).27 This sampling strategy will be applied until satu-
ration in the themes and concepts generated in the qual-
itative analysis is reached.
Patients: the study will include up to 200 patients with 
HF who are referred to the CR centres for rehabilita-
tion and receive REACH- HF treatment. Out of the 200 
patients, CR consultations of up to 48 patients (12 per 
site) receiving REACH- HF intervention will be audio 
recorded.
Intervention
REACH- HF is a home- based, health professional facil-
itated, 12- week CR programme supporting self- care 
in patients with HF, which has been codeveloped with 
patients, caregivers and clinicians. The programme is 
described in detail elsewhere11 12 28–30 and is summarised 
below.
The programme consists of:
 Ź The Heart Failure Manual for the patient provides 
information about HF to increase understanding of 
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Figure 1 The seven steps of successful REACH- HF facilitation. REACH- HF, Rehabilitation EnAblement in CHronic Heart 
Failure.
the condition and address common misconceptions, 
information about and strategies for managing the 
condition, and further information related to HF, 
such as lifestyle risk management, managing depres-
sion and anxiety and getting support from others.
 Ź A choice of two exercise training programmes; a chair- 
based programme (available on DVD and online) and 
a walking programme. Patients are recommended to 
engage in exercise three times per week, in addition 
to general physical activity.
 Ź A stress management programme, with relaxation 
techniques, provided in the manual and in audio 
format, to help cope with anxiety and depression.
 Ź A progress tracker designed for the patient to facilitate 
learning from experience through self- monitoring of 
behaviour and symptoms—prompting help- seeking, 
where necessary.
 Ź A family and friends resource to increase caregiver 
understanding of the condition, to enable them to 
support the patient in their self- care and to help them 
address their well- being.
 Ź Face- to- face and telephone facilitation over 12 
weeks by a health professional trained to deliver the 
REACH- HF programme.
Facilitator training
Three health professionals with CR and/or HF experi-
ence from each Beacon Site will attend a 3- day training 
course delivered by the HMD in Edinburgh. This training 
course will focus on the seven steps of successful facili-
tation of REACH- HF (figure 1) and include sessions 
on psychology, behaviour change, physical activity and 
exercise, engaging the caregiver and further content/
interaction designed to bring all of the components 
together.
The Beacon Sites will determine which members of 
the CR team will attend the REACH- HF training. The 
main requirement for the healthcare professional is the 
experience of delivering CR and/or of working with 
patients with HF. The facilitators will likely be HF/cardiac 
specialist nurses or physiotherapists/exercise specialists 
with qualifications and/or experience in the delivery of 
exercise- based CR programmes.
It is expected that site identification, training and 
set- up will take approximately 6 months. Following the 
set- up period, the Beacon Sites will have 12 months to 
deliver REACH- HF to 50 patients, during that time, qual-
itative interviews and audio recordings of REACH- HF 
sessions for selected patients will take place. At the end 
of Beacon Site activity, a quantitative data download will 
be requested from the NACR and an interim download 
will be requested 9 months from the end of the study to 
allow piloting of data- cleaning and processing procedures 
(stopping short of analysis).
Measures and procedures
Qualitative interviews
In- depth semistructured interviews and focus groups with 
NHS staff to include REACH- HF practitioners (physio-
therapists and CR nurses with experience in delivering 
centre- based CR, who had been trained to deliver the 
REACH- HF programme in a 3- day training course), 
service managers, clinical leads and commissioners. 
Interviews will take place at each Beacon Site (see online 
supplementary appendix 1 for the topic guide). Each 
identified staff member will, if possible, be interviewed 
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Table 1 Qualitative questions and their origins in the NPT construct and components
NPT construct Construct’s components Interview questions
Coherence (sense- 
making)
Differentiation Can you describe the REACH- HF intervention and how it differs from your 
usual way of working?
Communal speciication What is your colleagues understanding of the purpose of the REACH- HF 
intervention?
Individual speciication How does the intervention affect the nature of your work?
Internalisation In your opinion, what it the value of the REACH- HF intervention? To you? 
To your patients?
Cognitive 
participation 
(relational work)
Initiation Who are the individuals (you can include yourself) that drive REACH- HF 
forward and get others involved? What are their roles? What are they 
doing to support the project?
Enrolment How did the team need to change in order to introduce REACH- HF?
Legitimation How do you feel about being involved in the REACH- HF project?
Activation What is the future of REACH- HF in your service? What factors can enable 
the integration of REACH- HF into a cardiac rehabilitation service?
Collective action 
(operational work)
Interactional workability How easy or dificult has it been to integrate REACH- HF into your existing 
work?
Relational integration How has implementing REACH- HF affected working relationships within 
the team?
Skills and workability How do the skills of the staff delivering REACH- HF match the needs of the 
programme?
Contextual integration Was REACH- HF training suficient to allow for successful implementation? 
If not, what other topics or skills could have been included?
Are there enough resources available to support the REACH- HF 
programme?
Are there any other barriers to delivering REACH- HF on your patch?
Relexive monitoring 
(appraisal work)
Systematisation Are you in any way evaluating effectiveness, usefulness or impact of 
REACH- HF on the service?
Communal appraisal Do your colleagues consider the intervention worthwhile?
Individual appraisal Do you consider it worthwhile?
Reconiguration Can the REACH- HF intervention be easily modiied and improved to suit 
your way of working? If yes, in what way?
NPT, Normalisation Process Theory; REACH- HF, Rehabilitation EnAblement in CHronic Heart Failure.
twice (once at the beginning and once at the end of the 
data collection window) and one focus group will be held 
in each locality with identified study participants (at the 
midpoint of the data collection window). Interviews will 
be either face- to- face or by phone. The development of 
topic guides for qualitative interviews and focus groups 
was based on 4 constructs and 16 subdomains from 
the Normalisation Process Theory (NPT) framework 
(table 1). The topic guides content may be amended 
depending on feedback from stakeholders and the first 
few interviews.
Two video- conferencing peer supervision sessions 
will be available to all REACH- HF trained facilitators, 
provided by the HMD, as part of the REACH- HF training 
package. The researchers will observe and take notes 
from each of these sessions.
Fidelity assessment
All REACH- HF CR treatment sessions (four–six contacts), 
both face- to- face and phone- based, of approximately 48 
consenting patients (12 per site), will be audio recorded 
by the healthcare professionals delivering the programme. 
Each REACH- HF facilitator will be requested to audio 
record all treatment sessions for four patients with HF. 
The selection of which patients to include will be guided 
by the researchers, using a quasi- random process. Five 
months after the REACH- HF training, facilitators will 
be asked to invite all subsequent patients to take part 
in the study, until two willing patients with HF agree to 
have their treatment sessions recorded. Approximately 10 
months after the REACH- HF training, an email will be 
sent to repeat the invitation and audio recording process 
for the next two consenting patients.
The quality of delivery (intervention fidelity) of the 
recorded treatments will be assessed by the researcher 
(PD) using the same fidelity checklist used in the orig-
inal REACH- HF research study.11 This will allow compar-
ison with fidelity scores achieved in the clinical trial. The 
recordings for the first six patients will also be double 
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scored and two researchers (PD and CG) will discuss 
any differences in their scores to agree and ‘anchor’ the 
scoring process and minimise coder bias. If an agreement 
cannot be reached, a third reviewer (JJCSVvZ) will be 
appointed for arbitration.
The fidelity checklist is a 12- item checklist focused 
on identifying key delivery processes such as the use of 
a patient- centred communication style, making a plan 
of action and encouraging self- monitoring of progress 
(particularly with the exercise programme). The check-
list uses the Dreyfus scale of clinical skill acquisition,31 to 
rate clinical skills on a scale of 0–6 and is anchored such 
that a score of 3 or more represents adequate delivery 
quality for each item. Coding instructions are provided 
(online supplementary appendix 2).
REACH- HF facilitators will be asked to complete a brief 
self- rated fidelity checklist after each session they have 
recorded. This comprises questions about the same 12 
main components of the treatment and allows the facil-
itators to rate the occurrences of each feature (absence, 
minimal, some, sufficient, good, very good, excellent) 
(online supplementary appendix 3). The main reason for 
including a self- rated fidelity checklist is that an indepen-
dent observer rating is time- consuming/labour intensive, 
whereas a self- rating assessment might provide a prag-
matic, lower cost alternative for checking delivery quality 
for use in real- world clinical practice.
Finally, for each patient opting into the study, age, sex, 
time since diagnosis and severity of symptoms will be 
recorded by the healthcare professionals delivering the 
REACH- HF intervention.
Quantitative
At the end of the Beacon Site project period, a report will 
be requested from the NACR team based on the Univer-
sity of York on:
 Ź Number of referrals made to the Beacon Sites during 
the study period.
 Ź Number of patients with HF enrolled on the 
REACH- HF programme (attending at least one 
session).
 Ź CR attendance (average number of face- to- face and 
telephone sessions per patient).
 Ź Number of patients completing the REACH- HF 
programme (in the clinical trial11 patient adherence 
was defined as attendance at the first face- to- face 
contact with the facilitator and at least two facilitator 
contacts thereafter—at least one of which must have 
been face- to- face).
Summary data on key pre and post- programme meas-
ures will also be requested to enable comparison with 
changes in the intervention group observed in the clin-
ical trial. These include HRQoL—determined using the 
MLHFQ and exercise capacity—determined using the 
ISWT. The MLHFQ consists of 21 questions that rate on 
a scale of 0–5 (where 0 is not at all, 1 is very little and 5 is 
very much) how different HF symptoms (ie, swelling of 
ankles and legs, shortness of breath or tiredness, fatigue 
and poor energy levels) prevent the patient from living as 
they would have wanted to during the 4- week period prior 
to the first CR session. ISWT is an externally paced exer-
cise capacity test that can be administered in the field with 
minimal equipment and without medical supervision. 
The test has good test–retest reliability and it is an accept-
able alternative to (widely used to assess physical fitness 
and functional capacity of cardiac patients) exercise test 
with ECG monitoring or the cardiopulmonary exercise 
test.32 A recent study confirmed that a single ISWT is a 
valid, low resource, assessment of an estimate for physical 
fitness and functional capacity for CR patients.33
data analysis
Qualitative data
Digital recordings of interviews and focus groups will 
be transcribed verbatim and any potentially identifiable 
information, such as individual or location names, will 
be redacted. The transcripts (Word documents) will be 
uploaded into NVivo software to help organise the data 
for analysis.34 Illustrative quotes, that may be used in 
future presentations or publications, will be presented 
alongside pseudonyms to protect anonymity.
The transcripts will be analysed according to the prin-
ciples of framework analysis outlined by Ritchie and 
Spencer35 and using the four over- arching constructs 
of NPT (coherence, cognitive participation, collective 
action and reflexive monitoring) as an initial framework 
for coding the data.36 NPT suggests general mechanisms 
that are associated with successful implementation. 
These include service providers’ understanding of the 
new intervention and how it differs from standard prac-
tice, their motivation and attitude towards the healthcare 
innovation and the work they do to deliver and eval-
uate the intervention. NPT will provide a framework for 
generating questions for interviews and focus groups and 
analysing gathered data. See table 1 for more details on 
the application of NPT to the data collection.
Fidelity assessment
Implementation fidelity scores from the fidelity checklist 
will be collated at the level of the facilitator, the site and 
the total sample and presented using descriptive statis-
tics (means, ranges) using the same analytic approach 
as the original REACH- HF trial.11 Numerical data (0–6) 
from the Dreyfus scale of clinical skill acquisition will 
be converted into categorical (yes/no) data reflecting 
whether the session reached the adequate level of delivery 
(score 3 or above). Observer- rated treatment fidelity will 
be compared with self- rated fidelity from the post- session 
fidelity questionnaires completed by the REACH- HF facil-
itators at the end of each recorded session. The analytic 
approach to compare the two rating scales will be Pear-
son’s correlation for continuous scores37 and Gwet’s 
first- order agreement coefficient (the AC1 statistic) for 
categorical ratings.38
The fidelity assessment data sample reflects the sample 
size used to assess fidelity in the original REACH- HF 
 o
n
 June 23, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036137 on 21 June 2020. Downloaded from 
7Daw P, et al. BMJ Open 2020;10:e036137. doi:10.1136/bmjopen-2019-036137
Open access
Figure 2 Beacon Site evaluation and embedded processes for ongoing monitoring. NACR, National Audit of Cardiac 
Rehabilitation; NHS, National Health Service.
clinical trial. We require a minimum of four patient 
recordings per facilitator to be able to assess variation in 
performance between staff and between NHS sites.
Quantitative outcomes
Changes from pre to post- treatment in outcome data 
(MLHFQ and ISWT) will be reported as mean scores with 
95% CI within each Beacon Site. Mean change scores 
for patients receiving REACH- HF will be compared 
across Beacon Sites and also with the changes found in 
the REACH- HF trial. This comparison will take account 
of potential differences on patient characteristic and 
take due attention to the confidence intervals. Similarly, 
change scores for patients receiving REACH- HF will 
be compared with an aggregate change score from the 
NACR database for those who receive other forms of CR 
(primarily centre- based or digital CR). Subgroup anal-
yses will be conducted by the NACR team to determine 
variations in uptake and outcomes within our REACH- HF 
cohort by site, sex and other characteristics of interest (eg, 
area deprivation index, rurality). Data on the number of 
patients treated, uptake and completion rates and session 
attendance, will be presented using descriptive statistics. 
Figure 2 illustrates the interactions between the study’s 
aims and methods and how they link with the process of 
ongoing evaluation and scale- up.
Patient and public involvement
Patient preference and acceptability have been addressed 
extensively during the REACH- HF clinical trials.11 12 Six 
patients with HF and four caregivers have been consulted 
and informed the design of the REACH- HF programme. 
Patient and public involvement in the proposed study has 
included involving a member of the public to read and 
comment on the content of the study invitation letter, 
participant information sheet and the consent form 
designed for the study. Additionally, members of all CR 
teams involved in the study were consulted during the 
process of setting up the Beacon Sites on issues such as 
the feasibility of the study, selected outcome measures 
and the burden of participation in the study. At the end 
of the study, the final report will be shared with NHS 
staff at the participating Beacon Sites, allowing them to 
use it for service evaluation, future service planning and 
sharing of good practice.
dIsCussIon
The research- to- practice translation gap is well docu-
mented. It is common that evidence- based interven-
tions are not adopted into clinical settings and do not 
become routine practice. To narrow the translation gap, 
more insight is needed into mechanisms that allow for 
successful implementation of effective and cost- effective 
interventions. To advance the field, implementation 
theories and mechanisms need to be tested in real- world 
clinical settings.
The REACH- HF Beacon Site project is a multifaceted 
and interactive approach to a phased roll- out that aims to 
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disseminate the multicentre trial findings, increase aware-
ness of the REACH- HF intervention and explore replica-
bility of the intervention in new contexts. At the time of 
writing this protocol, four Beacon Sites in Scotland have 
been established and will contribute further data on the 
implementation of REACH- HF.39
In line with earlier recommendations for implemen-
tation research, this study will open a channel of feed-
back between researchers and implementers (NHS staff), 
with a common goal of improved service delivery for 
patients with HF. This study will provide an insight into 
the translation of the REACH- HF clinical trial findings 
into real- world practice and an in- depth understanding 
of the implementation process in the context of current 
NHS provision. These findings will inform the future, 
larger- scale implementation of REACH- HF, offer guid-
ance to policymakers, planners and commissioners of CR 
services, inform adaptations to the REACH- HF training 
package and intervention and facilitate adoption and 
spread of home- based CR for patients with HF in the UK.
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